European Regulators Approve AIDS Drug Fuzeon

Roche and Trimeris ( TRMS) said European regulators have approved the AIDS drug Fuzeon for use in the European Union.

The action means Fuzeon can be marketed in all 15 member countries of the E.U.

Fuzeon was approved by the Food and Drug Administration in the U.S. in March, and Swiss regulators cleared the drug earlier this month. The companies expect to introduce Fuzeon over the next several months on a country-specific basis.

Fuzeon works by preventing HIV from entering a cell, unlike other drugs that fight the virus after the fact. Shortly after the drug received approval in the U.S., Adam Feuerstein, a columnist for RealMoney.com, took an in-depth look at Fuzeon.

In early afternoon Nasdaq trading, shares of Trimeris were down 9 cents to $48.42.

More from Stocks

Musk's The Boring Company Just Got a Bit Less Boring

Musk's The Boring Company Just Got a Bit Less Boring

Tyson Foods CEO: We Aren't Done Making Deals

Tyson Foods CEO: We Aren't Done Making Deals

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June